Compressible but not redundant: knockout recovery and assay-panel architecture of the Neurospora crassa deletion phenome
G3: Genes, Genomes, Genetics · 04.11.2026 · 16 (11)
DOI: 10.1093/g3journal/jkag243 ↗Kurz gefasst
Fachartikel in der Zeitschrift G3: Genes, Genomes, Genetics, online erschienen am 27.08.2026. Verfasst von Ezekiel Ahn und 5 weiteren Autor:innen. Beteiligte Einrichtung: United States Department of Agriculture, Sustainable Perennial Crops Laboratory, Agricultural Research Service, Beltsville, MD 20705, United States. Hauptthemen laut MEDLINE: Neurospora crassa, Gene Deletion. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: U.S. Department of Agriculture, Agricultural Research Service, In-House Projects.
Abstract (Originalsprache)
Classical phenotype assays remain central to functional genetics, but a deletion phenome reflects both assay design and the set of knockouts that can be recovered for phenotyping. We integrated current Neurospora crassa knockout-availability records with a published complete-data phenome of 1,168 deletion strains scored across 10 growth and developmental assays. Among 8,892 genes with interpretable current knockout status, 7,239 had an available homokaryon and 1,653 were represented only as heterokaryons. Within iJDZ836 model genes, Dreyfuss-predicted essential genes were strongly enriched among heterokaryon-only knockouts; iJDZ836 genes as a class were also enriched, showing that the phenotyped matrix lies downstream of a substantial recovery filter. Within the complete phenome, the 10-assay panel resolved 180 discrete profiles. Exact enumeration of all 1,023 non-empty assay subsets showed that 90% of full-panel profile resolution required 8 assays and complete recovery required all 10. By contrast, 3 assays—basal hyphal growth rate, aerial hyphal height, and ascospore number—recovered at least 95% of full-panel normalized mutual information with the published 40-cluster architecture. Serial developmental traits were strongly dependent, but grouping the 10 assays into 6 biological modules preserved the main result: 3 modules comprising 4 assays recovered at least 95% of cluster normalized mutual information, whereas complete profile recovery required all 6 modules and all 10 assays. Thus, knockout recovery shapes which genes enter the phenome, and within that filtered set broad phenotype architecture is compressible while complete profile resolution is not.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- United States Department of Agriculture, Sustainable Perennial Crops Laboratory, Agricultural Research Service, Beltsville, MD 20705, United States.
- United States Department of Agriculture, Environmental Microbial and Food Safety Laboratory, Agricultural Research Service, Beltsville, MD 20705, United States.
- Department of Plant Pathology and Microbiology, Texas A&M University, College Station, TX 77843, United States.
ORCID-Profile: Ezekiel Ahn
Förderung
- U.S. Department of Agriculture, Agricultural Research Service
- In-House Projects
Zitieren
APA
Ahn, E., Baek, I., Oh, S., Kim, M. S., Meinhardt, L. W., & Magill, C. (2026). Compressible but not redundant: knockout recovery and assay-panel architecture of the Neurospora crassa deletion phenome. G3: Genes, Genomes, Genetics, 16(11). https://doi.org/10.1093/g3journal/jkag243
Vancouver
Ahn E, Baek I, Oh S, Kim MS, Meinhardt LW, Magill C. Compressible but not redundant: knockout recovery and assay-panel architecture of the Neurospora crassa deletion phenome. G3: Genes, Genomes, Genetics. 2026;16(11). doi:10.1093/g3journal/jkag243
BibTeX
@article{Ahn2026,
author = {Ahn, Ezekiel and Baek, Insuck and Oh, Sookyung and Kim, Moon S and Meinhardt, Lyndel W and Magill, Clint},
title = {Compressible but not redundant: knockout recovery and assay-panel architecture of the Neurospora crassa deletion phenome},
journal = {G3: Genes, Genomes, Genetics},
year = {2026},
volume = {16},
number = {11},
doi = {10.1093/g3journal/jkag243}
}
EUVIMED